Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12611428 | Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy | 🖼🧊📄§ | 2026-04-28 | 2040-12-02 | 0 | 31 |
| 12611415 | Methods and compounds for treatment of metabolic disease | 🖼🧊📄§ | 2026-04-28 | 2040-09-21 | 0 | 31 |
| 12612597 | Methods for preparing therapeutically active cells using microfluidics | 🖼🧊📄§ | 2026-04-28 | 2041-09-06 | 0 | 31 |
| 12612627 | Compositions and methods for increasing sodium current in cardiac cells | 🖼🧊📄§ | 2026-04-28 | 2041-04-19 | 0 | 31 |
| 12612427 | Aryl glucoside derivative, preparation method therefor and application thereof | 🖼🧊📄§ | 2026-04-28 | 2040-11-24 | 0 | 31 |
| 12611386 | Extended release pharmaceutical formulation | 🖼🧊📄§ | 2026-04-28 | 2041-09-22 | 0 | 31 |
| 12611458 | Chimeric receptors and methods of use thereof | 🖼🧊📄§ | 2026-04-28 | 2043-04-14 | 0 | 31 |
| 12612399 | Substituted 4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)thiophene-2-carboxamide derivatives and use thereof | 🖼🧊📄§ | 2026-04-28 | 2041-10-12 | 0 | 31 |
| 12611378 | Targeted release rifaximin compositions | 🖼🧊📄§ | 2026-04-28 | 2041-06-25 | 0 | 31 |
| 12611425 | Compositions and methods for treatment and prevention of pathogens | 🖼🧊📄§ | 2026-04-28 | 2043-08-14 | 0 | 31 |
| 12611431 | Approach to sustained production and delivery of nitric oxide and S-nitrosothiols | 🖼🧊📄§ | 2026-04-28 | 2043-10-16 | 0 | 31 |
| 12611439 | Ionic self-assembling peptides | 🖼🧊📄§ | 2026-04-28 | 2043-02-09 | 0 | 31 |
| 12612417 | Deuterated analogues of selenophenochromenes, synthesis thereof, and methods of using same agents | 🖼🧊📄§ | 2026-04-28 | 2040-07-21 | 0 | 31 |
| 12611388 | Weight loss formulation and methods | 🖼🧊📄§ | 2026-04-28 | 2042-05-27 | 0 | 31 |
| 12611400 | Solid lipid nano-composition containing berberine and cinnamonaldehyde effective in treating diabetes, dyslipidemia, and method of preparing the same | 🖼🧊📄§ | 2026-04-28 | 2040-12-04 | 0 | 31 |
| 12611385 | Use of two-dimensional nanomaterial in inhibition of coronavirus | 🖼🧊📄§ | 2026-04-28 | 2041-02-22 | 0 | 31 |
| 12611399 | Movement disorders | 🖼🧊📄§ | 2026-04-28 | 2042-05-01 | 0 | 31 |
| 12611379 | Lipid nano drug delivery system targeting brain lesion and preparation method and application thereof | 🖼🧊📄§ | 2026-04-28 | 2040-11-13 | 0 | 31 |
| 12611456 | Use of thiazole amide compounds for modulating human immune response | 🖼🧊📄§ | 2026-04-28 | 2040-09-16 | 0 | 31 |
| 12611390 | Methods and chemical compositions for treating skin conditions by providing long lasting skin PH control for improving skin barrier function | 🖼🧊📄§ | 2026-04-28 | 2045-08-21 | 0 | 31 |
| 12611448 | Targeting delivery system loaded with whole-cell components and use thereof | 🖼🧊📄§ | 2026-04-28 | 2040-11-05 | 0 | 31 |
| 12612362 | Anisomycin derivative and use of anisomycin and derivative thereof as GLP-1R agonist | 🖼🧊📄§ | 2026-04-28 | 2043-07-24 | 0 | 31 |
| 12612431 | Cyclic compounds for treating cancer | 🖼🧊📄§ | 2026-04-28 | 2042-06-10 | 0 | 31 |
| 12611460 | Eyedrop compositions | 🖼🧊📄§ | 2026-04-28 | 2039-09-18 | 0 | 31 |
| 12612451 | Method of treating neuromyelitis optica spectrum disorder (NMOSD) comprising administering an anti-C5 antibody | 🖼🧊📄§ | 2026-04-28 | 2040-12-08 | 0 | 31 |
| 12611461 | Bioorthogonal compositions | 🖼🧊📄§ | 2026-04-28 | 2045-04-16 | 0 | 31 |
| 12612612 | Methods for exon skipping and gene knockout using base editors | 🖼🧊📄§ | 2026-04-28 | 2039-07-19 | 0 | 31 |
| 12611402 | Compounds and their use for the treatment of ALPHA1-antitrypsin deficiency | 🖼🧊📄§ | 2026-04-28 | 2042-06-13 | 0 | 31 |
| 12612464 | Autoantibody specifically binding to NELL-1 and elevated NELL-1 polypeptide levels for identifying and treating membranous nephropathy | 🖼🧊📄§ | 2026-04-28 | 2040-09-18 | 0 | 31 |
| 12612462 | Treatment and inhibition of inflammatory lung diseases in patients having risk alleles in the genes encoding IL33 and IL1RL1 | 🖼🧊📄§ | 2026-04-28 | 2043-06-07 | 0 | 31 |
| 12611423 | Medical use of tafoxiparin | 🖼🧊📄§ | 2026-04-28 | 2043-05-02 | 0 | 31 |
| 12612441 | Polypeptide and therapeutic uses thereof | 🖼🧊📄§ | 2026-04-28 | 2040-01-07 | 0 | 31 |
| 12612426 | Aryl glucoside derivative | 🖼🧊📄§ | 2026-04-28 | 2040-11-24 | 0 | 31 |
| 12612449 | HIV-1 antibodies | 🖼🧊📄§ | 2026-04-28 | 2041-06-10 | 0 | 31 |
| 12612444 | T cell receptors targeting mutations in RNA splicing factors | 🖼🧊📄§ | 2026-04-28 | 2040-11-25 | 0 | 31 |
| 12611444 | IL-36 cytokine expressing oncolytic viruses for treating cancer | 🖼🧊📄§ | 2026-04-28 | 2042-03-17 | 0 | 31 |
| 12611433 | Anaerostipes sp B2131 strain and application thereof in inflammatory bowel diseases | 🖼🧊📄§ | 2026-04-28 | 2041-01-08 | 0 | 31 |
| 12611440 | Fusion proteins and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2040-09-03 | 0 | 31 |
| 12611409 | Combination therapy using a chemokine receptor 2 (CCR2) antagonist and a PD-1/PD-L1 inhibitor | 🖼🧊📄§ | 2026-04-28 | 2042-03-15 | 0 | 31 |
| 12611405 | Agent that increases the expression of the BCL2-associated agonist of cell death for the treatment of cancer | 🖼🧊📄§ | 2026-04-28 | 2038-03-28 | 0 | 31 |
| 12612629 | Duchenne muscular dystrophy-related exonic splicing enhancer, sgRNA and gene editing tool, and applications | 🖼🧊📄§ | 2026-04-28 | 2040-09-30 | 0 | 31 |
| 12612447 | April and BAFF inhibitory immunomodulatory proteins and methods of use thereof | 🖼🧊📄§ | 2026-04-28 | 2043-03-17 | 0 | 31 |
| 12612610 | Compositions and methods for controlling blood pressure | 🖼🧊📄§ | 2026-04-28 | 2042-11-11 | 0 | 31 |
| 12611429 | Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy | 🖼🧊📄§ | 2026-04-28 | 2042-08-03 | 0 | 31 |
| 12611413 | Pharmaceutical compositions comprising meloxicam | 🖼🧊📄§ | 2026-04-28 | 2045-07-08 | 0 | 31 |
| 12611393 | Treatment of pain by targeting NR4A1 | 🖼🧊📄§ | 2026-04-28 | 2040-08-31 | 0 | 31 |
| 12611418 | Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin | 🖼🧊📄§ | 2026-04-28 | 2045-08-11 | 0 | 31 |
| 12611416 | Methods of treating ischemic stroke at risk for cerebral or cerebellar edema | 🖼🧊📄§ | 2026-04-28 | 2045-05-13 | 0 | 31 |
| 12611406 | Oxopiperazine derivatives for the treatment of cancer | 🖼🧊📄§ | 2026-04-28 | 2041-06-18 | 0 | 31 |
| 12612456 | CD19 antibodies and methods of using the same | 🖼🧊📄§ | 2026-04-28 | 2040-04-07 | 0 | 31 |